Martin Aigner

Martin Aigner is Associate Professor and Private Lecturer at the Karl Landsteiner Private University of Health Sciences, where he heads the Clinical Department of Psychiatry and Psychotherapeutic Medicine at Tulln University Hospital. He also teaches at the Medical University of Vienna and the University for Continuing Education Krems. A board member and president (2022–2025) of the Austrian Society for Psychiatry, Psychotherapy, and Psychosomatics (ÖGPP), he is also involved in the Austrian Pain Society and Austrian Balint Society.

His research interests center on the integration of biological, psychological, and social factors in psychiatry, with key areas including transitional psychiatry, obsessive-compulsive and mood disorders, the gut-brain axis, and the impact of environmental toxins like mycotoxins on mental health. He leads the PhD program in 'Mental Health and Neuroscience' and supervises doctoral research.

His recent publications reflect a strong trend in interdisciplinary mental health research, combining clinical psychiatry with neuroscience, nutrition, and digital health. Themes include neurofeedback for addiction, microbiome influences on depression, and psychosomatic manifestations in chronic conditions. His work often involves neuroimaging and clinical trials.

• Three scientific prizes from the Austrian Pain Society
• Scientific prize from the Vienna Association for Neurology and Psychiatry
• Contributor to WFSBP guidelines on pharmacological treatment of eating disorders
• Co-author of guidelines for post-viral conditions

He serves as principal investigator in multiple funded projects, including studies on depression and the microbiome, probiotics, and psychosis triggers. He is also co-investigator in follow-up care and community mental health initiatives. Aigner is editor-in-chief of psychopraxis. neuropraxis and advocates for digital health literacy and sustainable mental health structures, particularly in youth care.

He leads the Research Center for Transitions Psychiatry, emphasizing early intervention, resilience, and patient empowerment through recovery companions. His team includes habilitated senior physicians, fostering innovation in clinical and research settings.